Kevin Xie

Title: Kevin Xie: Innovator in Pharmaceutical Compositions

Introduction

Kevin Xie is a notable inventor based in Anaheim, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of long-term sustained release compositions for bisphosphonate drugs. His work is crucial in addressing various bone diseases, including osteoporosis.

Latest Patents

Kevin Xie holds a patent for a "Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate." This innovative composition includes an aqueous suspension of a solid that comprises a salt of a bisphosphonate drug and a salt of pentavalent phosphorus oxoacid. The patent highlights the potential of these compositions to treat a variety of bone diseases effectively.

Career Highlights

Kevin Xie is currently employed at Amphastar Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Amphastar has positioned him as a key player in the pharmaceutical industry, particularly in the area of drug formulation.

Collaborations

Some of his coworkers include Jack Yongfeng Zhang and Mary Ziping Luo, who contribute to the collaborative environment at Amphastar Pharmaceuticals.

Conclusion

Kevin Xie's innovative work in pharmaceutical compositions demonstrates his commitment to improving treatments for bone diseases. His contributions are vital to the ongoing advancements in the pharmaceutical field.